In a landmark decision more than two decades in the making, the US Food and Drug Administration announced its approval of a genetically modified Atlantic Salmon variant on Thursday. The AquAdvantage salmon, which was initially developed back in 1989 and submitted for approval in 1995, grows far faster than its conventionally bred brethren. The FDA has deemed it safe for human consumption, equally nutritious as other salmon varieties and not dangerous to the environment. And since the GMO salmon is considered nutritionally equivalent to regular salmon supermarkets will be able to carry the fish without having to label them being GMO.
You might be familiar with the concept of 3D-printed medical equipment, but you’re going to have to get used to seeing 3D-printed medicine, too. The US Food and Drug Administration has approved its first drug manufactured using 3D printing, Aprecia’s epilepsy-fighting Spritam.